Patient Guide: Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 5 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06600802
Status: 🟢 Enrolling Now
Condition: Castration-resistant Metastatic Prostate Cancer, Treated by 177Lutetium-PSMA-617 (Lu-PSMA)
Phase: NA

Find a Study Location Near You

This study is available at 5 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Clermont-Ferrand,
  • La Tronche,
  • Pierre-Bénite,
  • • And 2 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily